NEW YORK (GenomeWeb) – Thermo Fisher Scientific said on Thursday it has reached a deal with NewLab Engineering for the exclusive global distribution rights to the Card Processing Automation technology for DNA-based human identification.

Thermo Fisher will be the sole distributor and servicing agent of NewLab's CPA300 and CPA200 card processing instruments. CPA technology is used by forensic, paternity, and research laboratories to prepare DNA samples for human identification.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: The sea anemone is sequenced, a team describes a CRISPR/Cas9-based approach to label specific sites in the genome, and more. 

In a short video, CNN introduces viewers to a fecal transplant poop donor and explains how the treatments are made.

Researchers are testing the use of transgenically altered diamondback moths as an alternative to pesticides in controlling the bugs.

Two recent papers published in Science and Nature Medicine describe work that may result in a universal vaccine for the flu.